Skip to main content

Handelsbanken Fonder AB

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1398318 STOCKHOLM, V7

Position in HALO

as of Jun 30, 2026 · filed Jul 10, 2026
Position Value
$49,458,734
+$17,565,833 QoQ
Shares Held
631,899
+28.1% QoQ
Ownership
0.533%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#3
of 70 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. HALO ranks #2 (7.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 HALO
Halozyme Therapeutics, Inc.
This page
631,899 $49,458,734

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $49,458,734 631,899
2026-03-31 $31,892,901 493,469
2025-12-31 $39,832,783 591,869
2025-09-30 $28,482,982 388,369
2025-06-30 $11,047,435 212,369
2025-03-31 $16,977,862 266,069
2024-12-31 $24,692,382 516,469
2024-09-30 $112,715,233 1,969,169
2024-06-30 $58,275,056 1,112,969
2024-03-31 $33,710,254 828,669
2023-12-31 $9,094,710 246,069
2023-09-30 $911,795 23,869
2023-06-30 $796,028 22,069
2023-03-31 $10,390,315 272,069
2022-12-31 $1,176,066 20,669
2022-09-30 $817,252 20,669
2022-06-30 $909,436 20,669
2022-03-31 $939,931 23,569
2021-12-31 $1,144,738 28,469
2021-09-30 $1,158,118 28,469
2021-06-30 $1,292,777 28,469
2021-03-31 $978,422 23,469
2020-12-31 $1,305,601 30,569
2020-09-30 $1,071,409 40,769
2020-06-30 $1,093,016 40,769